Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
SAN DIEGO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from...
SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
SAN DIEGO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.39 | 13 | 3 | 3.3992 | 2.98 | 930482 | 3.10605539 | CS |
| 4 | 0.42 | 14.1414141414 | 2.97 | 3.78 | 2.965 | 777546 | 3.23959991 | CS |
| 12 | 1.64 | 93.7142857143 | 1.75 | 3.8001 | 1.68 | 1017505 | 2.90822361 | CS |
| 26 | 1.69 | 99.4117647059 | 1.7 | 3.8001 | 1.42 | 672920 | 2.58200514 | CS |
| 52 | 1.64 | 93.7142857143 | 1.75 | 3.8001 | 1.42 | 651367 | 2.55173036 | CS |
| 156 | 1.64 | 93.7142857143 | 1.75 | 3.8001 | 1.42 | 651367 | 2.55173036 | CS |
| 260 | 1.64 | 93.7142857143 | 1.75 | 3.8001 | 1.42 | 651367 | 2.55173036 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
